{
  "id": 1688802,
  "title": "STAT+: A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass",
  "url": "https://urgent.news/2026/08/18/stat-a-pill-that-mimics-exercise-early-results-on-drug-designed-to",
  "topic": "science",
  "section": "Science",
  "published": "2026-08-18T10:00:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/08/18/enveda-pill-mimics-exercise-phase-one-trial-leptin-weight-loss-maintenance/"
  },
  "original_language": "en",
  "account": "A new pill designed to mimic the effects of exercise has shown promising early results in maintaining weight loss and muscle mass, according to Enveda, a biotech company based in Colorado. The drug, ENV-308, works by suppressing appetite and preserving lean muscle mass, addressing a common issue with GLP-1 drugs where patients often lose muscle as they lose weight. Enveda's drug candidate, lac-phe, was discovered by Stanford scientists and shown to suppress appetite and reduce obesity in animals in a 2022 Nature paper. If successful in clinical trials, ENV-308 would be the first \"leptin sensitizer in a pill.\"",
  "summary": "Colorado biotech Enveda reports preliminary results on a drug to help people maintain weight loss after GLP-1 use. Just don't call it exercise in a pill.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}